FDA Drug Shortage Database
Lisdexamfetamine (Vyvanse) shortage
The FDA Drug Shortage Database lists 34 of 108 lisdexamfetamine presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on July 14, 2023. 74 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule II
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg capsule | 4 | 8 | 0 |
| 10mg tablet | 0 | 3 | 0 |
| 20mg capsule | 6 | 7 | 0 |
| 20mg tablet | 0 | 3 | 0 |
| 30mg capsule | 5 | 8 | 0 |
| 30mg tablet | 0 | 3 | 0 |
| 40mg capsule | 5 | 8 | 0 |
| 40mg tablet | 0 | 3 | 0 |
| 50mg capsule | 5 | 8 | 0 |
| 50mg tablet | 0 | 3 | 0 |
| 60mg capsule | 4 | 9 | 0 |
| 60mg tablet | 0 | 3 | 0 |
| 70mg capsule | 5 | 8 | 0 |
Which presentations are listed?
Limited or unavailable now (34)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated May 12, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Unavailable; Delay in shipping of the drug |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | Hikma Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) | Rhodes Pharmaceuticals L.P. | Current posted January 11, 2024, updated June 24, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) | Solco Healthcare US, LLC | Current posted July 14, 2023, updated June 29, 2026 | Limited Availability; Shortage of an active ingredient |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Limited Availability; Other |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | Elite Laboratories, Inc. | Current posted July 14, 2023, updated October 2, 2026 | Limited Availability; Shortage of an active ingredient |
Listed now, available (74)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Lannett Company, Inc. | Current posted September 20, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | Rhodes Pharmaceuticals L.P. | Current posted July 14, 2023, updated June 24, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current posted July 14, 2023, updated October 5, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | SpecGx LLC | Current posted July 14, 2023, updated August 20, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Teva Pharmaceuticals USA, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Lannett Company, Inc. | Current posted July 14, 2023, updated October 1, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Alvogen | Current posted July 14, 2023, updated October 2, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Apotex Corp. | Current posted November 1, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) | Amneal Pharmaceuticals | Current posted July 14, 2023, updated October 6, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Sun Pharmaceutical Industries, Inc. | Current posted July 14, 2023, updated September 18, 2026 | Available |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Novadoz Pharmaceuticals LLC | Current posted July 14, 2023, updated September 16, 2026 | Available |
| Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
| Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Takeda Pharmaceuticals USA Inc. | Current posted July 14, 2023, updated September 15, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Methylphenidate | ADHD | In shortage | 31 labelers | $0.158 per tablet 10 mg tablet |
| Amphetamine and dextroamphetamine | ADHD | In shortage | 25 labelers | $0.233 per tablet 10 mg tablet |
| Dexmethylphenidate | ADHD | No current entry | 13 labelers | $1.45 per capsule 10 mg capsule |
| Amphetamine | ADHD | No current entry | 13 labelers | $0.449 per tablet 10 mg tablet |
| Dextroamphetamine | ADHD | No current entry | 14 labelers | $0.373 per tablet 10 mg tablet |
| Dexmethylphenidate and serdexmethylphenidate | ADHD | No current entry | none listed | $14.40 per capsule 26.1 mg-5.2 mg capsule |
| Methamphetamine | ADHD | No current entry | 3 labelers | $5.10 per tablet 5 mg tablet |
| Atomoxetine | ADHD | No current entry | 20 labelers | $0.442 per capsule 40 mg capsule |
| Guanfacine | ADHD | A presentation being discontinued | 36 labelers | $0.147 per tablet 1 mg tablet |
| Viloxazine | ADHD | No current entry | none listed | $12.74 per capsule 200 mg capsule |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage